Brits who find themselves waking up at 2am or 3am for no reason are being told not to brush it off as “just one of those normal things”. In new advice aimed at people who wake at the same time most ...

Brits who find themselves stirring at 2am or 3am without explanation are being advised not to dismiss it as "just one of those normal things". In fresh guidance targeting those who wake up at ...

Caroline Connor's concerns about her son Mason's development began around his first birthday, when she noticed he wasn't talking or using any words. Their pediatrician didn't seem worried, but the ...

The Trump administration has announced a drug called leucovorin (or folinic acid), currently used to treat the side effects of cancer drugs, will be made available to treat symptoms of autism in some ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The folinic acid supplement will be prescribed for a subset of children with autism who have “cerebral folate deficiency,” but experts caution, “it’s not a cure" Semi / Alamy Stock Photo F.D.A. issued ...

Folinic acid, also known as leucovorin, is drawing worldwide attention after United States health officials, including Dr Mehmet Oz, highlighted its potential benefits for some children with autism.

Sept 22 (Reuters) - (This Sept 22 story has been corrected to say folinic acid, not folic acid, in paragraph 1) The U.S. Food and Drug Administration announced approval of leucovorin, or folinic acid, ...

WASHINGTON, Sept 22 (Reuters) - (This Sept 22 story has been corrected to say folinic acid, not folic acid, in paragraph 6) U.S. President Donald Trump on Monday linked autism to childhood vaccine use ...

Dr Reddy’s Laboratories has launched the novel molecule ‘Tegoprazan’, for acid-related gastrointestinal diseases in India. Dr Reddy’s launches tegoprazan (50 mg) under the brand name PCAB. Tegoprazan ...

Dr. Reddy’s Laboratories Ltd. on Tuesday announced the launch of a novel gastrointestinal therapy in India, betting on a next-generation acid blocker to strengthen its branded portfolio in a market ...

https://www.thehindubusinessline.com/companies/dr-reddys-launches-tegoprazan-for-treatment-of-acid-related-disorders-in-indian-market/article70057206.ece Copy Dr ...